Innovation
Fri, Oct 15, 2021 2:22 PM

Egis Inaugurates Two New Plants in Körmend

Two technology-intensive developments, carried out with state subsidies, were completed at Egis Pharmaceuticals PLC’s Körmend site (Hungary). The investments were inaugurated by Péter Szijjártó, Minister of Foreign Affairs and Trade, and by the company’s CEO, Dr. István Hodász on 15 October.  In addition to a new packaging plant, Egis has also established a plant with special knowledge and technology requirements, typically suitable to manufacture oncology products.  Thus, Egis is now able to implement all value-creating processes within the field of oncology, from development to active ingredient and finished product manufacturing.
Innovation

Egis Inaugurates Two New Plants in Körmend

Two technology-intensive developments, carried out with state subsidies, were completed at Egis Pharmaceuticals PLC’s Körmend site (Hungary). The investments were inaugurated by Péter Szijjártó, Minister of Foreign Affairs and Trade, and by the company’s CEO, Dr. István Hodász on 15 October.  In addition to a new packaging plant, Egis has also established a plant with special knowledge and technology requirements, typically suitable to manufacture oncology products.  Thus, Egis is now able to implement all value-creating processes within the field of oncology, from development to active ingredient and finished product manufacturing.
Fri, Oct 15, 2021 2:22 PM
Author:
Fri, Oct 15, 2021 2:22 PM
Author:
Play video

The project, which started in the spring of 2018, was completed with a total cost of about HUF 7 billion and received a grant of more than HUF 1 billion based on Individual Government Decision (EKD/TECH-2018/5).

As part of the investment package, Egis has completed its oncology product development and manufacturing infrastructure. In the newly established finished product manufacturing plant - used for products that require special manufacturing conditions - the company has installed equipment that enables state-of-the-art technological innovations.

"With our new investment, all steps of the development and manufacturing of oncology products can be implemented at Egis. Thus, we can contribute to the treatment of oncology patients with up-to-date generic products that are, regarding all processes, fully controlled and reliable, domestically developed and manufactured " - said Dr. István Hodász, CEO of Egis Pharmaceuticals PLC.

As another element of the investment package that was now inaugurated, Egis set up a new packaging plant as well. The company’s Körmend site performs more than half of the company's packaging tasks, the old packaging plant has been operating at full capacity, and there was no possibility of expanding it.  The new packaging plant, located on the property purchased at the beginning of 2018 and adjacent to the production site, can be further expanded in the future, and will be able to meet the growing market demands with flexibility.

The facility complies with both international quality assurance requirements (GMP) and standards for the validation of computerized systems and electronic data processing, while being suitable for the temporary storage of finished products and for product serialization that supplements manufacturing processes and certifies authenticity.

#Körmend #_Extremely important #award
Related articles from Egis Magazine
Events

The 2024 Hungarian Innovation Grand Prize Contest was announced at Egis
More
Egis World

Ten Years Together – Egis Pharmaceuticals PLC Remains the Partner of the Körmend Basketball Team
More
Innovation

Egis' medicines won the Innovation Grand Prize
More

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox